News
-
-
-
-
PRESS RELEASE
EQS-Adhoc: Viromed Medical AG seeks extensive cooperation with a major global Group
Viromed Medical AG is seeking extensive cooperation with a major global Group in the pharmaceutical sector for the application of cold atmospheric pressure plasma in medicine. Expected initial revenues in the low double-digit million range by the second half of 2025 -
-
-
-
PRESS RELEASE
Viromed Medical AG is expanding its Management Board – Christian Strauch has been appointed as a new member of the Management Board
Viromed Medical AG appoints Christian Strauch as new Management Board member to enhance global marketing of cold plasma technology. Uwe Perbandt named Chairman -
-
PRESS RELEASE
EQS-Adhoc: Viromed Medical AG plans to acquire all shares in pharmedix GmbH by means of a capital increase against a contribution in kind, excluding subscription rights.
Viromed Medical AG plans to acquire pharmedix GmbH through a capital increase, expanding their healthcare portfolio. The acquisition aims for a revenue growth of 35% in 2025
